Publicacións nas que colabora con Maria Cespón Fernández (31)

2023

  1. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

2022

  1. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 375-383

  2. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  3. Nutrition status, obesity and outcomes in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  5. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

2021

  1. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  2. Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation

    Journal of the American Medical Directors Association, Vol. 22, Núm. 10, pp. 2190-2195

  3. Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry

    Journal of Geriatric Cardiology, Vol. 18, Núm. 10, pp. 809-815

  4. Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry

    Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416

2020

  1. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers in Acute Coronary Syndrome and Preserved Ventricular Ejection Fraction

    Angiology, Vol. 71, Núm. 10, pp. 886-893

  2. Impact of anticoagulation in patients with dementia and atrial fibrillation. Results of the CardioCHUVI-FA registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 877-884

  3. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 6, pp. 878-887

  4. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction

    Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122

  5. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

  6. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14

  7. Incidence, prognosis and predictors of heart failure after acute myocardial infarction

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 8-14

  8. New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation

    Journal of the American Heart Association, Vol. 9, Núm. 22, pp. e016836

  9. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

  10. Prevalence and Prognostic Significance of Malnutrition in Patients With Acute Coronary Syndrome

    Journal of the American College of Cardiology, Vol. 76, Núm. 7, pp. 828-840